Curis
CRIS
#11244
Rank
S$1.85 M
Marketcap
S$0.77
Share price
9.39%
Change (1 day)
-60.40%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): S-$18.37

According to Curis's latest financial reports the company's current EPS (TTM) is S-$18.17. In 2025 the company made an earnings per share (EPS) of S-$30.42 an increase over its 2024 EPS that were of S-$179.63.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$18.37-39.61%
2025S-$30.42-83.07%
2024S-$179.63-22.15%
2023S-$230.73-26.17%
2022S-$312.5022.3%
2021S-$255.52-25.37%
2020S-$342.40-30.93%
2019S-$495.71-2.02%
2018S-$505.93
2016S-$1,150-10%
2015S-$1,278138.1%
2014S-$536.5940%
2013S-$383.28-25%
2012S-$511.0466.67%
2011S-$306.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.97-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.80-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$4.22-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.56-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$4.06-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$4.39-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA